SEC Filings for Cannabics Pharmaceuticals Inc (CNBX)

$ 0.4245   0.0545 (+14.73%) Volume: 324.05k 12:05 PM EST 18-Feb-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
8-KCurrent report pursuant to Section 13 or 15(d)206/29/2011
SC 13DGeneral statement of acquisition of beneficial ownership106/29/2011
3Initial statement of beneficial ownership of securities106/28/2011
8-KCurrent report pursuant to Section 13 or 15(d)206/20/2011
8-KCurrent report pursuant to Section 13 or 15(d)606/07/2011
8-KCurrent report pursuant to Section 13 or 15(d)205/13/2011
8-KCurrent report pursuant to Section 13 or 15(d)205/10/2011
8-KCurrent report pursuant to Section 13 or 15(d)404/22/2011
10-QGeneral form for quarterly reports under Section 13 or 15(d)304/14/2011
10-QGeneral form for quarterly reports under Section 13 or 15(d)301/18/2011
NT 10-QNotification of inability to timely file Form 10-Q or 10-QSB101/14/2011
10-KAnnual report pursuant to Section 13 or 15(d)511/29/2010
8-KCurrent report pursuant to Section 13 or 15(d)309/30/2010
DEF 14COther definitive information statements108/11/2010
PRE 14COther preliminary information statements107/30/2010
123456789101112131415